Big Pharmas Eyeing on Personalized Medicine Market to Sustain Growth
As blockbusters drugs continue to expire, the prospect of smaller markets and shrinking revenues remains a big challenge for the pharmaceutical companies for the coming decade, says RNCOS in its latest research study.
View full press release